Stockhub

Helixmith Co., Ltd: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 10:2610:26, 22 September 2022 95.149.241.133 talk 1,044 bytes +1,044 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological diseases. The company's pip..."
Retrieved from "https://stockhub.co/research/Helixmith_Co.,_Ltd"